Ala147Thr and C+1542G polymorphisms in the TAFI gene are not asssociated with a higher risk of venous thrombosis in FV Leiden carriers.
Morange
P E
PE
Aillaud
M F
MF
Nicaud
V
V
Henry
M
M
Juhan-Vague
I
I
D020016:Activated Protein C Resistance / Q000150:complications / Q000235:genetics*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000483:Alleles; D019943:Amino Acid Substitution; D025901:Carboxypeptidase B2 / Q000235:genetics*; D005165:Factor V / Q000235:genetics*; D005260:Female; D016368:Frameshift Mutation; D005838:Genotype; D006239:Haplotypes / Q000235:genetics; D006579:Heterozygote; D006801:Humans; D015810:Linkage Disequilibrium; D008297:Male; D008875:Middle Aged; D016254:Mutagenesis, Insertional; D020125:Mutation, Missense; D010641:Phenotype; D017354:Point Mutation; D011110:Polymorphism, Genetic; D011655:Pulmonary Embolism / Q000453:epidemiology / Q000235:genetics; D012306:Risk; D019851:Thrombophilia / Q000235:genetics*; D013924:Thrombophlebitis / Q000453:epidemiology / Q000235:genetics; D020246:Venous Thrombosis / Q000453:epidemiology* / Q000235:genetics
C095381:factor V Leiden; D005165:Factor V; D025901:Carboxypeptidase B2